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ABSTRACT: The purpose of this study was to assess whether different stages of
chronic obstructive pulmonary disease (COPD) severity de ned according to the Global
Initiative for Chronic Obstructive Lung Disease (GOLD) criteria correlate with
meaningful differences in health status.
A total of 381 COPD patients, aged 73¡6 yrs, were classi ed in the  ve GOLD
stages. Disease-speci c (St George Respiratory Questionnaire (SGRQ)) and generic
indexes of health status were measured in all patients. Multivariate analysis of
covariance or Kruskal Wallis tests were used to compare health status indexes across
the spectrum of GOLD stages of COPD severity.
GOLD stages of COPD severity signi cantly differed in SGRQ components and
Barthel9s index, but not in the indexes assessing cognitive and affective status and
quality of sleep. The largest variation in health status was observed at the transition
from stage IIa to stage IIb, while there were no other signi cant differences between
consecutive stages. Both female sex and comorbidity were associated with a greater
impact of COPD on the health status.
In conclusion, the upper limit of stage IIb (forced expiratory volume in one second of
49%) marks a threshold for dramatic worsening of health status. Progression of chronic
obstructive pulmonary disease severity from stage 0 to stage IIa does not correspond to
any meaningful difference in health status.
Eur Respir J 2003; 22: 444–449.
*Institute of Internal Medicine and Geriatrics,
Catholic University, Rome, #San Raffaele
Cittadella della Carita` Foundation, Taranto,
}Institute of General Medicine and Pulmonol-
ogy, University of Palermo, Palermo and
zInstitute of Internal Medicine and Geriatrics,
Federico II University, Naples, Italy.
Correspondence: R. Antonelli-Incalzi, Dept
of Geriatrics (CEMI), Universita` Cattolica,
Largo A. Gemelli n. 8, 00168, Roma, Italy.
E-mail: raffaele_antonelli@rm.unicatt.it
Fax: 39 063051911
Keywords: Chronic obstructive pulmonary
disease, elderly, Global Initiative for Chronic
Obstructive Lung Disease guidelines, health
status
Received: November 5 2002
Accepted after revision: April 18 2003
The Salute Respiratoria nell9Anziano: Res-
piratory Health in the Elderly Study (SaRA)
was supported by a research grant from
Boehringer Ingelheim, Italy.
The Global Initiative for Chronic Obstructive Lung Dis-
ease (GOLD) has recently released a four-stage classi cation
of chronic obstructive pulmonary disease (COPD) severity to
guide the therapeutic approach [1]. In these patients, stage 0
de nes the condition characterised by classic clinical symp-
toms but normal spirometry. Stage I de nes patients with a
forced expiratory volume in one second (FEV1)/forced vital
capacity (FVC) of<70%, and an FEV1 of>80% predicted,
with or without chronic symptoms that may or may not be
aware of disease status. Stage II (FEV1/FVC<70%, FEV1
30–79%) is split into substages IIa (FEV1 50–79%) and IIb
(FEV1 30–49%) according to the greater rate of exacerbation
experienced by patients in substage IIb, which in turn is
inversely related to health status [2]. Finally, stage III (FEV1/
FVC <70% and either FEV1 <30% pred, hypoxaemia, or
clinical signs of right heart failure) is expected to be associated
with the worst health status.
However, the GOLD guidelines do not clearly de ne the
rationale supporting the suggested classi cation scheme. Pre-
vious experience shows that worsening health status only
re ects increased COPD severity categorised on the basis of
FEV1 % pred, to a limited extent. Instead, comorbidity plays
an important role in de ning health status, mainly in mild-to-
moderate COPD [3]. The Salute Respiratoria nell9Anziano:
Respiratory Health in the Elderly (SaRA) study provides a
unique opportunity of verifying whether and to what extent
GOLD stages of COPD severity correlate with health status.
The availability of disease-speci c indexes of health status
and of indexes of performance allows detection of the
differences between stages. Thus, the present analysis has
been performed to test the discriminatory capacity of the
GOLD staging system versus health status.
Methods
A detailed description of the SaRA study is available
elsewhere [4, 5]. Brie y, the SaRA study aims to de ne the
relationship between disease severity and health status and its
main determinants in a population aged>64 yrs with chronic
respiratory problems. In the present study, 381 patients with a
de nite diagnosis of COPD or nonobstructive bronchitis were
classi ed according to GOLD stages of COPD severity. A
diagnosis of nonobstructive bronchitis, corresponding to
GOLD stage 0, was made if patients complained of cough
and sputum for " 3 months?yr-1 for " 2 yrs consecutively
(Chemical Industries Barel (CIBA) criteria), but had normal
spirometry.
Patients were considered to be affected by COPD if they
ful lled either of the following criteria: 1) they met the CIBA
criteria, had an FEV1/FVC of<70% pred and no change or an
FEV1 increase of>12%, but not FEV1 normalisation after
100 mg fenoterol; or 2) they neither met the CIBA criteria nor
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reported history of wheeze in the last year, had an FEV1/FVC
of<70% pred, an FEV1 of<80% pred and an FEV1 increase
of<12% after 100 mg fenoterol.
A diagnosis of asthma was made if patients did not meet
the CIBA criteria and had either of the following: 1) an FEV1
of>80% pred and a history of wheeze in the last year; 2) an
FEV1 of<80% pred, an FEV1 increase of>12% after 100 mg
fenoterol and a history of wheeze in the last year; or 3)
an FEV1 of <80% pred, an FEV1 increase of >12% after
100 mg fenoterol and no history of wheeze in the last year.
Asthmatics were excluded from the study.
Health status was measured using disease-speci c indexes
("Symptoms", "Activity" and "Impacts" components and "Total"
score of the St George Respiratory Questionnaire (SGRQ))
and generic indexes assessing cognitive performance (Mini
Mental Status Examination (MMSE)), affective performance
(15-item Geriatric Depression Scale (15-GDS)), physical
performance (Barthel9s index, 6-min walking test) and quality
of sleep (index of disturbed sleep from the Established
Populations for Epidemiologic Studies of the Elderly ques-
tionnaire (EPESE)), respectively [6–12]. The 6-min walking
distance is expressed as per cent of the predicted based on age,
sex, height and weight (WT % pred) [13]. The meanings of
individual indexes and information on their validity in older
COPD patients are presented in table 1.
Differences in health status indexes among groups were
assessed as follows.
1) Multivariate analysis of covariance (MANCOVA) for
indexes with both normal distribution and homogeneous
variance: MMSE, WT % pred, SGRQ Impacts, SGRQ Total,
EPESE. The effects of three factors (GOLD stage, sex, living
conditions (alone, with relatives/others)) and four covariates
previously proven (waist:hip ratio, occiput-wall distance,
number of comorbid diseases) or the likelihood of affecting
the health status in COPD (age) were also assessed [3, 14].
The Wilk9s lambda coef cient was computed to quantify
the effects of individual factors and their effect on health
status. The contribution of individual covariates toward an
explanation of the distribution of the dependent variables was
expressed by the respective F value. For each dependent
variable, a multiple regression versus all the covariates was
also performed and the b coef cient was assumed as a
measure of the relationship between the dependent variable
and the corresponding covariate. Post hoc differences between
stages were assessed by the Scheffe` test.
2) Kruskal Wallis test for indexes lacking normal distribu-
tion and/or homogeneous variance: 15-GDS, Barthel9s index,
SGRQ Symptoms and Activity. Differences between stages
were assessed using the Mann-Whitney U-test.
The linear regression analysis was performed to assess the
relationship between SGRQ Total and airway obstruction, as
expressed by FEV1 %.
Results
The general characteristics of patients are summarised in
table 2. A geriatric and poorly educated population was used
in this study, a minority of which continued to smoke. About
one in four patients was female and one in  ve lived alone.
The average occiput-wall distance of 6.6 cm indirectly testi es
that osteoporosis was a common problem. The average nutri-
tional status expressed by the body mass index, was normal,
whereas the relatively high waist:hip ratio was consistent with
a prevalently visceral distribution of fat. Most of the drugs
used were intended for nonrespiratory problems. Cardiovascular
diseases, diabetes mellitus, visual and hearing impairment
were the most common comorbid conditions.
The demographical characteristics and respiratory function
indexes of patients grouped according to GOLD stages are
reported in table 3. Stages had comparable age and propor-
tion of patients living alone, whereas the prevalence of
females was higher in stages 0–IIA. According to classi ca-
tion criteria, both FEV1 % and FEV1/FVC were normal in
GOLD stage 0.
MANCOVA results are reported in table 4. Increasing
Table 1. – Indexes of health status measured in the Salute Respiratoria nell9Anziano: Respiratory Health in the Elderly study
Index Measure Range of values Validity in COPD
SGRQ#
Symptoms Measures frequency and severity of
respiratory symptoms
0–100} Designed for and validated
in COPD patients [6]
Activity Assesses physical activities that either
cause or are limited by dyspnoea
0–100}
Impacts Quanti es the impact of the respiratory
disease on daily life
0–100}
Total A summary measure of health status 0–100}
6-min walking test Can be considered as a measure of
sub-maxima physical performance
Normal values can be
predicted on the basis of
age, sex, body and weight
A highly reliable measure
in COPD [10]
Barthel9s index Measures the patient9s independence
in self-care and mobility
0–100z Proved to be highly correlated
with disease-specic measure
of health status in COPD [14]
MMSE Commonly used to screen dementia 0–30
Abnormal values: MMSE<24
The most reliable screening
instrument in older adults [7, 12]
15-GDS Largely used to screen depression 0–15
Abnormal values>5
Proved to be valid in a
variety of settings [8]
EPESE index of
disturbed sleep
Classi es four types of sleep
disturbances: dif culty initiating sleep;
waking at night; feeling of tiredness after
waking in the morning; waking too early
0–16§ Validity proved in older home-
dwelling subjects with chronic
diseases including COPD [11]
COPD: chronic obstructive pulmonary disease; SGRQ: St George Respiratory Questionnaire; MMSE: Mini Mental Status Examination; 15-GDS:
15-item Geriatric Depression Scale; EPESE: Established Populations for Epidemiologic Studies of the Elderly questionnaire. #: all disease-speci c
indexes of health status; }: 0=no impairment, 100=maximal impairment; z: 0=complete dependency, 100=complete independence; §: 0=normal sleep,
16=maximally disturbed sleep.
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GOLD stage was associated with a dramatic worsening of
health status (Wilk9s lambda 0.85, p<0.001), as re ected by
the SGRQ Impacts and Total, but not by MMSE, WT % pred
and EPESE. Female sex was also associated with greater
scores in sleep, SGRQ Impacts and Total, i.e. with poorer
quality of sleep and worse disease-speci c health status
(table 5). The interaction between living conditions (alone)
and sex (female) (Wilk9s lambda for interaction 0.95, p=0.02)
but not living alone per se (Wilk9s lambda 0.96, p=0.054) was
associated with worse health status. No interaction between
sex and GOLD stage was recorded. Comorbidity (F=2.66,
p=0.02) and age (F=2.33, p=0.05), but not the occiput-wall
distance (F=0.65, p=0.66) and waist:hip ratio (F=1.15, p=0.33),
contributed to determining the distribution of the dependent
variables.
Comorbidity was associated with a higher EPESE score,
i.e. with worse quality of sleep (b=0.175, p<0.01) and higher
Impacts (b=0.137, p=0.02) and Total (b=0.115, p=0.05) SGRQ
scores. Age was associated with higher Total SGRQ score
(b=0.136, p=0.02).
Post-hoc analysis of differences between GOLD stages
showed important differences in both SGRQ Impacts and
Total between nonconsecutive stages but only between IIa
and IIb consecutive stages.
The differences among GOLD stages in health status
indexes assessed by the Kruskal Wallis test are reported in
table 6. Both SGRQ Symptoms and Impacts worsened from
stage 0 to stage III, but the only consecutive stages signi -
cantly differing in these indexes were IIa and III. Variability
in health status scores was very high: 23% of stage 0 and
25.5% of stage I patients scored>64, which correspond to the
average score of patients in stage IIb, on the SGRQ
Symptoms.
Table 3. –Demographical and respiratory function char-
acteristics of patients grouped according to Global Initiative
for Chronic Obstructive Lung Disease (GOLD) staging
GOLD stage
0 I IIa IIb III
Age yrs 74¡7 74¡5 73¡5 72¡5 73¡6
Females# 29/89 12/48 28/129 9/89 3/26
Living alone 24/87 9/48 27/124 24/88 8/26
FEV1} 92.3¡23.5 89.8¡9.3 63.7¡8.5 40¡5.7 26.2¡2.8
FEV1/FVCz 78¡6.4 63¡4.6 56.7¡7.9 41.4¡9 36.7¡11.6
Data are presented as mean¡SD or %. FEV1: forced expiratory volume
in one second; FVC: forced vital capacity.#: Chi-squared 15.3, p=0.005;
}: F=275, p<0.001;z: F=295, p<0.001.
Table 4. –Distribution of health status indexes by Global
Initiative for Chronic Obstructive Lung Disease (GOLD) stages
and sex, as assessed by multivariate analysis of covariance
Index GOLD stage p-value
0 I IIa IIb III
Subjects n 89 48 129 89 26
SGRQ Impacts 11¡11 11¡10 14¡10 21¡11 26¡12 <0.001
SGRQ Total 30¡22 36¡19 38¡20 50¡16 62¡17 <0.001
MMSE 26¡3 26¡3 25¡3 26¡4 26¡3 0.75
EPESE 4¡4 4¡4 3¡4 4¡4 3¡4 0.06
6-min WT % pred 78¡27 75¡26 72¡27 61¡27 59¡22 0.07
Data are presented as mean¡SD unless otherwise stated. Signi cant
(p<0.01) differences between GOLD stages were as follows. St George
Respiratory Questionnaire (SGRQ) Impacts and Total: 0–IIb, 0–III, I–
IIb, I–III, IIa–IIb, IIa–III; 6-min walk distance (6-min WT) %
predicted; 0–IIb. MMSE: Mini Mental Status Examination; EPESE:
Established Populations for Epidemiologic Studies of the Elderly
questionnaire.
Table 5. –Distribution of health status indexes by sex, as
assessed by multivariate analysis of covariance
Index Females Males p-value
SGRQ Impacts 47¡14 39¡11 0.03
SGRQ Total 21¡24 16¡21 0.01
MMSE 27¡2.2 26¡2.8 0.57
EPESE 6.3¡4.2 3.2¡4.2 <0.001
6-min WT % pred 72¡27 68¡27 0.49
Data are presented as mean¡SD unless otherwise stated. SGRQ: St
George Respiratory Questionnaire; MMSE: Mini Mental Status
Examination; EPESE: Established Populations Epidemiologic Studies
of the Elderly questionnaire; 6-min WT % pred: 6-min walked distance
expressed as a per cent of the predicted.
Table 6. –Distribution of health status indexes by Global
Initiative for Chronic Obstructive Lung Disease (GOLD)
stages, as assessed by the Kruskal Wallis test
Index GOLD stage p-value
0 I IIa IIb III
Subjects n 89 48 129 89 26
SGRQ Symptoms 40¡26 44¡22 47¡24 64¡17 60¡21 <0.001
SGRQ Activity 38¡27 41¡22 49¡26 65¡19 72¡16 <0.001
Barthel9s index 98¡4 98¡5 96¡7 94¡4 91¡10 <0.001
15-GDS 5¡4 4¡3 3¡3 4¡3 5¡3 0.055
Data are presented as mean¡SD unless otherwise stated. Signi cant
(p<0.01) differences between GOLD stages were as follows. St George
Respiratory Questionnaire (SGRQ) Symptoms: 0–IIb, 0–III, I–IIb,
IIa–IIb; SGRQ Activity: 0–IIa, 0–IIb, 0–III, I–IIb, I–III, IIa–IIb, IIa–
III; Barthel9s index: 0–IIb, 0–III, I–IIb, I–III, IIa–III; 15-GDS: 15-item
Geriatric Depression Scale.
Table 2. –General characteristics of the patients
Characteristics
Females 81 (21.3)
Age yrs 73¡5.6
Education>8 yrs 53 (13.9)
Living alone 92 (24.1)
Occiput-wall distance cm 6.6¡3.9
Waist:hip ratio 0.96¡0.09
Body mass index kg?cm-2 26¡3.9
Daily used drugs 3.6¡2.2
Daily used respiratory drugs 1.5¡1.4
Current smokers 81 (21.3)
Main comorbid diseases
Hypertension 67 (17.6)
Ischaemic heart disease 59 (15.2)
Diabetes mellitus 53 (13.9)
Visual impairment 42 (11)
Hearing loss 39 (10.3)
Congestive heart failure II NYHA class 38 (10)
Prostatic hypertrophy# 22¡7.3
Cerebrovascular disease 20 (5.2)
Tumours 19 (5)
Peptic ulcer 15 (3.9)
Parkinson9s disease 7 (1.8)
Data are presented as n (%) or mean¡SD. NYHA: New York Heart
Association. #: of male patients.
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Figure 1 is a box plot showing the distribution of SGRQ
scores by GOLD stage. Clinically signi cant differences, i.e.
of a magnitude of>4, in the average value (or median) were
observed between all consecutive stages with the exception of
0–I. A consistent overlap of recorded values among stages 0, I
and IIa as well as between stages IIb and III is also evident.
The linear regression analysis yielded the following
equation:
SGRQTotal~64:603{0:3885FEV1% …1†
Where R=-0.4605 and R2=0.212. Thus, the severity of airway
obstruction explains only one  fth of the observed variance in
health status, as re ected by the SGRQ Total.
Discussion
The present results demonstrate that the GOLD staging
system marks important differences in health status assessed
by a disease-speci c index or the Barthel index. The age of the
patients may explain why the Barthel9s index but not the WT
% pred could distinguish between groups, as the elderly are
exposed to the negative impact of disabling conditions mainly
on the basic and instrumental activities of daily living.
Accordingly, a test assessing submaximal physical perfor-
mance is expected to lose part of its discriminatory capacity in
an elderly population. Indexes of affective status and quality
of sleep could not distinguish GOLD stages, although
depression and disturbed sleep are common COPD-related
problems. Indeed, depression and sleep problems seem to
complicate COPD in its earliest stage but, at variance from
physical limitations, their prevalence and severity do not
parallel increasing COPD severity. The relatively low size of
the stage III population, i.e. of patients most exposed to the
risk of cognitive impairment, may explain why MMSE also
failed to distinguish GOLD stages.
The present  ndings have been obtained in a rigorously
selected population and corrected for the confounding effect
of several variables proven or supposed to affect the health
status. Thus, they demonstrate that GOLD staging of COPD
corresponds to important differences in health status between
stages IIa and IIb, but not between other consecutive stages.
This suggests that the boundary between stages IIa and IIb
marks a turning point in the evolution of health status in
COPD patients. In contrast, no signi cant change in health
status marks the earliest progression of COPD from stage 0 to
I and from I to IIa, as well as its ultimate transition from
stage IIb to III. The size inequality of groups IIb and III and
the consistent overlapping of health status scores recorded in
consecutive stages are likely to explain these  ndings.
An index of airway obstruction accounted for a minority of
the explained variance in SGRQ Total score. This  nding and
the great interindividual variability in health status within a
given GOLD stage clearly shows that health status cannot be
inferred from the GOLD stage and should be systematically
assessed in the individual patient. It would appear that a
disease-speci c instrument is recommended due to its superior
discriminatory capacity. However, a generic index of physical
capability, such as the Barthel9s index, can represent a
valuable alternative because it requires very little time and
allows comparison between patients with different main
diseases.
The observed greater susceptibility of females to the
negative effects of COPD on the health status represents an
original  nding. Indeed, the authors could  nd only one
report showing that female sex weakens the positive effects of
rehabilitation on disease-related health status in COPD [15].
A similar sex effect has been reported for cardiovascular
rehabilitation programmes [16]. Whatever its determinants,
the observed phenomenon deserves special consideration.
Indeed, females represent a rapidly increasing proportion of
all COPD patients, as can be inferred from the dramatically
rising prevalence of cigarette smoking among females, as well
as from the greater impact of smoke on lung function of
females [17, 18]. Furthermore, COPD will become the  fth
leading cause of disability in af uent countries by year 2020
[19]. The dramatic rise in the prevalence of female patients is
hypothesised to result in a greater than expected effect of
COPD on the health status and, as a consequence, the need of
care.
Patients classi ed in the 0 and I GOLD stages have an
FEV1 of>80% pred and, thus, are excluded from previous
classi cations of COPD severity [20–22]. This prevents any
comparison of health status classi cations achieved by
GOLD and previous staging systems. Nevertheless, the
 nding that about one of four patients in GOLD stage 0
scored higher than the average patient in GOLD stage IIb
suggests that health status frequently deteriorates even in
the absence of bronchial obstruction, possibly because of
respiratory symptoms or coexisting nonrespiratory problems.
The impact of comorbidity on selected measures of health
status in this and in a previous study supports the latter
hypothesis [3].
The limitations of this study deserve to be discussed. First,
survival bias might have attenuated the differences between
the most severe stages. Only a longitudinal study can test
this hypothesis. Secondly, the lack of statistically signi cant
differences between consecutive stages other than IIa and IIb
does not guarantee that clinically signi cant differences were
absent. Indeed, stages I and IIa, as well as stages IIb and
III, differed in SGRQ Total score by six and 12 points,
respectively, i.e. of a magnitude well over the clinically
relevant minimal difference of four [6]. These differences
might qualify as statistically signi cant in a larger population.
Finally, distinguishing long-standing asthma from COPD
is quite problematic in the elderly [23]. The authors9
diagnostic criteria were carefully developed and rigorously
applied but could not guarantee the absence of occasional
misclassi cations.
In conclusion,  ndings from this study show that staging
chronic obstructive pulmonary disease according to Global
Initiative for Chronic Obstructive Lung Disease guidelines
does correspond to important differences in health status, but
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Fig. 1. – Box plot showing the distribution of St George Respiratory
Questionnaire (SGRQ) scores by Global Initiative for Chronic
Obstructive Lung Disease (GOLD) stage. Numbers on the y-axis
show the minimal clinically signi cant difference. Error bars show
SD, small boxes show the mean and larger boxes show the SE.
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that health status patterns of consecutive stages overlap
remarkably. Further research is needed to verify whether
integrating the Global Initiative for Chronic Obstructive
Lung Disease stage with selected measures of health status
will allow de nition of subgroups with a distinctive prognosis.
Special attention should be paid to the heterogeneity of health
status in stages 0 and 1: selected health status patterns might
be a marker of chronic obstructive pulmonary disease pro-
gression rate. Prospectively assessing these topics will improve
knowledge of the Global Initiative for Chronic Obstructive
Lung Disease classi catory and prognostic implications, as
well as of the feasibility of a mixed, i.e. physiopathological-
clinical and health-status indicator based, chronic obstructive
pulmonary disease staging system. Finally, the important
differences in health status between stages IIa and IIb and the
lack of signi cant differences between lower grade consecu-
tive stages suggests that every effort should be made to
prevent the progression of chronic obstructive pulmonary
disease, since passing the boundary of a forced expiratory
volume in one second of<50% of predicted is likely to herald
a dramatic decline of the health status.
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